Monitor updates on the joint venture's decision to refurbish or replace Sea Pines and any insurance recovery. The reaffirmed guidance suggests management views the financial impact as manageable, but prolonged closure or higher-than-expected remediation costs could pressure future results.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $137.54entry
- T+1 · 8d ago +2.62%α +0.26% · $141.15
- T+5 · 4d ago +2.51%α −0.09% · $140.99
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Encompass Health disclosed the indefinite closure of its 90-bed Sea Pines Rehabilitation Hospital in Florida due to flood damage from torrential rains on Nov. 1-2, 2026. The company reaffirmed its full-year 2026 guidance (revenue $6.45B-$6.50B, Adjusted EBITDA $1.395B-$1.415B, adjusted EPS $6.23-$6.37), noting that Sea Pines contributed approximately $44M in revenue and $14M in Adjusted EBITDA for the first nine months of 2026. The closure is a material but isolated operational disruption, with the company planning to exclude related expenses and insurance proceeds from non-GAAP measures.
Key Facts
- Sea Pines Rehabilitation Hospital (90 beds) closed indefinitely due to flood damage from Nov. 1-2, 2026 torrential rains.
- All patients safely evacuated; all employees accounted for.
- Joint venture between Encompass Health and Holmes Regional Medical Center (Health First).
- For first nine months of 2026, Sea Pines had net operating revenue of approximately $44M, Adjusted EBITDA of approximately $14M, and 1,876 total discharges.
- Full-year 2026 guidance reaffirmed: net operating revenue $6.45B-$6.50B, Adjusted EBITDA $1.395B-$1.415B, adjusted EPS $6.23-$6.37.
- Company intends to exclude remediation and closure-related expenses, and any insurance proceeds, from non-GAAP measures.
- Joint venture evaluating alternatives for refurbishing or replacing the hospital.
Financial Impact
Sea Pines contributed ~$44M revenue and ~$14M Adjusted EBITDA in first nine months of 2026; full-year guidance unchanged suggests immaterial impact relative to $6.45B-$6.50B revenue and $1.395B-$1.415B Adjusted EBITDA.
Risk Factors
- Indefinite closure duration and remediation costs are uncertain.
- Potential for higher operating expenses during closure that may not be fully excluded from GAAP results.
- Risk of patient volume loss or referral pattern shifts in the Melbourne, Florida market.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000785161-26-000242 |
| Document: november2026pressrelease.htm | 0000785161-26-000242 |
| Document: 0000785161-26-000242-index-headers.html | 0000785161-26-000242 |
| Document: 0000785161-26-000242-index.html | 0000785161-26-000242 |
| Document: 0000785161-26-000242.txt | 0000785161-26-000242 |
Track record
14 reports on EHC
3 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +8.88% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 6, 202610d ago 8-K Neutral 4/10 Viewing Entry $137.54 to $141.15 Now $142.11 +3.32% ▲ +2.62% +0.26% vs SPY
- Oct 28, 202619d ago 8-K Bullish 6/10 No price data
- Oct 28, 202619d ago Press Release Bullish 6/10 Entry $131.49 to $135.90 Now $142.11 +8.08% ▲ +3.35% +5.13% vs SPY
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $122.09 to $131.49 Now $142.11 +16.40% ▲ +7.70% +8.08% vs SPY
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $124.09 to $124.10 Now $142.11 +14.52% ▲ +0.01% −0.70% vs SPY
- Oct 22, 202625d ago Press Release Neutral 2/10 Entry $126.01 to $124.09 Now $142.11 +12.78% ▼ −1.52% −1.00% vs SPY
- Oct 1, 20266w ago Press Release Neutral 1/10 Entry $119.80 to $120.97 Now $142.11 +18.62% ▲ +0.98% +0.30% vs SPY
- Sep 1, 202610w ago Insider Cluster Neutral 3/10 Entry $122.05 to $121.18 Now $142.11 +16.44% ▼ −0.71% −1.16% vs SPY
- Aug 11, 202613w ago Insider Cluster Bearish 5/10 Entry $125.35 to $124.83 Now $142.11 −13.37% ▲ +0.41% +0.67% vs SPY
- Aug 5, 202614w ago Press Release Bullish 7/10 Entry $124.82 to $125.23 Now $142.11 +13.85% ▲ +0.33% −0.28% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers